Transforming cell and gene therapy manufacturing with high throughput discovery and design of enhanced cell lines. Join our team: http://jobs.lever.co/64xbio
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $55M
Founded date: 2018
Investors 6
| Date | Name | Website |
| - | Fifty Year... | fiftyyears... |
| - | Alix Ventu... | alix.vc |
| 12.01.2022 | Future Ven... | future.ven... |
| - | Y Combinat... | ycombinato... |
| 27.01.2022 | Lifeforce ... | lifeforcec... |
| - | Refactor C... | refactor.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.01.2022 | Series A | $55M | - |
Mentions in press and media 2
| Date | Title | Description |
| 19.01.2022 | 64x Bio Raises $55M in Series A Financing | 64x Bio, a San Francisco, CA-based synthetic biology company, closed a $55m Series A financing. The round was led by Lifeforce Capital, with participation from Northpond Ventures, individual investor Michael Chambers (co-founder and former ... |
| 19.01.2022 | A George Church spinout fighting the viral vector bottleneck in cell and gene therapy lands $55M | A synthetic biology company spun out of George Church’s lab is set to tackle the gene therapy manufacturing bottleneck, and it just landed $55 million in a Series A financing round to do so. George Chruch 64x Bio comes ... |